BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 36550816)

  • 21. Combined Evaluation of Tumor-Infiltrating CD8 + and FoxP3 + Lymphocytes Provides Accurate Prognosis in Stage IA Lung Adenocarcinoma.
    Kinoshita F; Takada K; Yamada Y; Oku Y; Kosai K; Ono Y; Tanaka K; Wakasu S; Oba T; Osoegawa A; Tagawa T; Shimokawa M; Oda Y; Mori M
    Ann Surg Oncol; 2020 Jun; 27(6):2102-2109. PubMed ID: 31773516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Foxp3 overexpression decreases sensitivity to chemotherapy in mouse Lewis lung cancer cells.
    Li C; Yang W; Gai X; Zhang Y; Li Y; Fu H
    Mol Med Rep; 2012 Nov; 6(5):977-82. PubMed ID: 22961482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of tumor-infiltrating lymphocytes differs depending on histological type and smoking habit in completely resected non-small-cell lung cancer.
    Kinoshita T; Muramatsu R; Fujita T; Nagumo H; Sakurai T; Noji S; Takahata E; Yaguchi T; Tsukamoto N; Kudo-Saito C; Hayashi Y; Kamiyama I; Ohtsuka T; Asamura H; Kawakami Y
    Ann Oncol; 2016 Nov; 27(11):2117-2123. PubMed ID: 27502728
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes of CD4+CD25+FOXP3+ and CD8+CD28- regulatory T cells in non-small cell lung cancer patients undergoing surgery.
    Chen C; Chen D; Zhang Y; Chen Z; Zhu W; Zhang B; Wang Z; Le H
    Int Immunopharmacol; 2014 Feb; 18(2):255-61. PubMed ID: 24345703
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor-associated immune factors are associated with recurrence and metastasis in non-small cell lung cancer.
    Yan X; Jiao SC; Zhang GQ; Guan Y; Wang JL
    Cancer Gene Ther; 2017 Feb; 24(2):57-63. PubMed ID: 28084319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IL-10 derived from Hepatocarcinoma cells improves human induced regulatory T cells function via JAK1/STAT5 pathway in tumor microenvironment.
    Zhang S; Gan X; Qiu J; Ju Z; Gao J; Zhou J; Shi C; Zhu Y; Li Z
    Mol Immunol; 2021 May; 133():163-172. PubMed ID: 33667986
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Salidroside regulates tumor microenvironment of non-small cell lung cancer via Hsp70/Stub1/Foxp3 pathway in Tregs.
    Wen Z; Liu T; Zhang Y; Yue Q; Meng H; He Y; Yang Y; Li M; Zheng J; Lin W
    BMC Cancer; 2023 Aug; 23(1):717. PubMed ID: 37528345
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic Value of EZH2 in Non-Small-Cell Lung Cancers: A Meta-Analysis and Bioinformatics Analysis.
    Fan K; Zhang CL; Qi YF; Dai X; Birling Y; Tan ZF; Cao F
    Biomed Res Int; 2020; 2020():2380124. PubMed ID: 33299862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Image Analysis-based Assessment of PD-L1 and Tumor-Associated Immune Cells Density Supports Distinct Intratumoral Microenvironment Groups in Non-small Cell Lung Carcinoma Patients.
    Parra ER; Behrens C; Rodriguez-Canales J; Lin H; Mino B; Blando J; Zhang J; Gibbons DL; Heymach JV; Sepesi B; Swisher SG; Weissferdt A; Kalhor N; Izzo J; Kadara H; Moran C; Lee JJ; Wistuba II
    Clin Cancer Res; 2016 Dec; 22(24):6278-6289. PubMed ID: 27252415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High tumor hexokinase-2 expression promotes a pro-tumorigenic immune microenvironment by modulating CD8+/regulatory T-cell infiltration.
    Kim S; Koh J; Song SG; Yim J; Kim M; Keam B; Kim YT; Kim J; Chung DH; Jeon YK
    BMC Cancer; 2022 Nov; 22(1):1120. PubMed ID: 36320008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune Microenvironment Differences Between Squamous and Non-squamous Non-small-cell Lung Cancer and Their Influence on the Prognosis.
    Meng X; Gao Y; Yang L; Jing H; Teng F; Huang Z; Xing L
    Clin Lung Cancer; 2019 Jan; 20(1):48-58. PubMed ID: 30341017
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigation on the regulatory T cells signature and relevant Foxp3/STAT3 axis in esophageal cancer.
    Yang L; Zhao Q; Wang X; Pilapong C; Li Y; Zou J; Jin J; Rong J
    Cancer Med; 2023 Feb; 12(4):4993-5008. PubMed ID: 36226375
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of the Significance of Immune Cell Infiltration and Prognosis of Non-Small-Cell Lung Cancer by Bioinformatics.
    Sun H; Sui B; Li Y; Yan J; Cao M; Zhang L; Liu S
    J Healthc Eng; 2021; 2021():3284186. PubMed ID: 34603645
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated Circulating CD4
    Hu X; Gu Y; Zhao S; Hua S; Jiang Y
    Cancer Biother Radiopharm; 2019 Jun; 34(5):325-333. PubMed ID: 30925076
    [No Abstract]   [Full Text] [Related]  

  • 35. Targeting SNORA38B attenuates tumorigenesis and sensitizes immune checkpoint blockade in non-small cell lung cancer by remodeling the tumor microenvironment via regulation of GAB2/AKT/mTOR signaling pathway.
    Zhuo Y; Li S; Hu W; Zhang Y; Shi Y; Zhang F; Zhang J; Wang J; Liao M; Chen J; Qian H; Li D; Sun C
    J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35577506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of key microRNAs and hub genes in non-small-cell lung cancer using integrative bioinformatics and functional analyses.
    Song F; Xuan Z; Yang X; Ye X; Pan Z; Fang Q
    J Cell Biochem; 2020 Mar; 121(3):2690-2703. PubMed ID: 31692035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Comprehensive Bioinformatic Analysis for Identification of Myeloid-Associated Differentiation Marker as a Potential Negative Prognostic Biomarker in Non-Small-Cell Lung Cancer.
    Zhou M; Chen Y; Gu X; Wang C
    Pathol Oncol Res; 2022; 28():1610504. PubMed ID: 36061144
    [No Abstract]   [Full Text] [Related]  

  • 38. Rothia in Nonsmall Cell Lung Cancer is Associated With Worse Survival.
    Takabe YJ; Allen E; Allen L; McCarthy R; Varma A; Bace M; Sharma P; Porter C; Yan L; Wu R; Bouchard RJ; Yendamuri S
    J Surg Res; 2024 Apr; 296():106-114. PubMed ID: 38271794
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of the cell cycle characteristics of non-small cell lung cancer and its relationship with tumor immune microenvironment, cell death pathways, and metabolic reprogramming.
    Cao S; Xiao S; Zhang J; Li S
    Front Endocrinol (Lausanne); 2023; 14():1147366. PubMed ID: 37091844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interferon regulatory factor 4 (IRF4) is overexpressed in human non‑small cell lung cancer (NSCLC) and activates the Notch signaling pathway.
    Qian Y; Du Z; Xing Y; Zhou T; Chen T; Shi M
    Mol Med Rep; 2017 Nov; 16(5):6034-6040. PubMed ID: 28849037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.